Dr. Goodman said, "Mount Sinai offers unparalleled opportunities to bring to bear new technologies and innovations in drug discovery targeting major neuropsychiatric disorders, such as Schizophrenia, Alzheimer's Disease, Depression, Autism, PTSD, OCD and Bipolar Disorder. I look forward to working with my colleagues in the other brain sciences to attain this goal."
Dr. Goodman has published more than 200 articles in scientific journals and has received several prestigious honors, including the Mysell Lecture Award from Harvard University and recognition as one of the Best Doctors in America from 2003-2008.
Dr. Goodman is a member of the American College of Neuropsychopharmacology, Distinguished Fellow of the American Psychiatric Association, and Acting Chair of the FDA's Psychopharmacologic Drug Advisory Committee. He also serves on the Governor's Council on Suicide Prevention in Florida.
A native New Yorker, Dr. Goodman graduated from Columbia University with a BS in electrical engineering. He received his medical degree from Boston University and completed his internship, residency, and a research fellowship at Yale University School of Medicine where he remained on faculty until 1993.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation's oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 50,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center
'/>"/>
| Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved |